FATAL SUPPRESSION OF SYMPTOMS DURING HORMONE THERAPY

Publisher： John Wiley & Sons Inc

E-ISSN： 1532-5415|3|11|890-892

ISSN： 0002-8614

Source： JOURNAL OF AMERICAN GERIATRICS SOCIETY, Vol.3, Iss.11, 1955-11, pp. : 890-892

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Emotional Suppression Tendencies as Predictors of Symptoms, Mood, and Coping Appraisals During AC Chemotherapy for Breast Cancer Treatment

By Schlatter Melanie  

Annals of Behavioral Medicine, Vol. 40, Iss. 1, 2010-08 ,pp. : 15-29

Springer Publishing Company

Access to resources Recommend Favorite

Hormone Replacement Therapy after Treatment of Breast Cancer: Effects on Postmenopausal Symptoms, Bone Mineral Density and Recurrence Rates

By  

Oncology, Vol. 60, Iss. 3, 2001-04 ,pp. : 199-206

Karger

Access to resources Recommend Favorite

Failure to Maintain a Suppressed Level of Serum Testosterone during Long-Acting Depot Luteinizing Hormone-Releasing Hormone Agonist Therapy in Patients with Advanced Prostate Cancer

By  

Urologia Internationalis, Vol. 77, Iss. 2, 2006-08 ,pp. : 135-138

Karger

Access to resources Recommend Favorite

Profound Changes in Sex Hormone Levels during Cross‐Sex Hormone Therapy of Transsexuals do not Alter Serum Cholesterol Acceptor Capacity

By  

THE JOURNAL OF SEXUAL MEDICINE, Vol. 12, Iss. 6, 2015-06 ,pp. : 1436-1439

John Wiley & Sons Inc

Access to resources Recommend Favorite

Maintaining Normal Levels of Ionized Calcium during Citrate-Based Renal Replacement Therapy Is Associated with Stable Parathyroid Hormone Levels

By  

Nephron Clin Pract, Vol. 124, Iss. 1-2, 2013-11 ,pp. : 124-131

Karger

Access to resources Recommend Favorite